1996
DOI: 10.1016/0014-5793(96)00285-2
|View full text |Cite
|
Sign up to set email alerts
|

A role for ADP‐ribosylation factor 1, but not COP I, in secretory vesicle biogenesis from the trans‐Golgi network

Abstract: A synthetic N-myristoylated peptide corresponding to the amino-terminal domain of ADP-ribosylation factor 1 (ARF1) markedly increases, in a cell-free system using post-nuclear supernatant from PC12 cells, the biogenesis of constitutive secretory vesicles and immature secretory granules from the trans-Goigi network (TGN). The related N-myristoylated ARF4 peptide only weakly stimulates, and the non-myristoylated ARF1 and ARF4 peptides inhibit, the biogenesis of these secretory vesicles. In a modified cell-free s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
24
1

Year Published

1997
1997
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(25 citation statements)
references
References 39 publications
0
24
1
Order By: Relevance
“…Alternatively, this peptide may have a nonspecific disruptive effect on Golgi membranes (38). It has also been reported that an amino-terminal mARF1 peptide facilitates AP-1 recruitment onto immature secretory granules in the TGN (35) and stimulates the formation of secretory vesicles (34,36). In these studies high levels of myristoylated peptide were required for optimal activity (100 M) (34,35), raising the possibility that the effect was due to some residual activity in the amino terminus of ARF1.…”
Section: Fig 7 Ap-1 and Coatomer Bindingmentioning
confidence: 80%
“…Alternatively, this peptide may have a nonspecific disruptive effect on Golgi membranes (38). It has also been reported that an amino-terminal mARF1 peptide facilitates AP-1 recruitment onto immature secretory granules in the TGN (35) and stimulates the formation of secretory vesicles (34,36). In these studies high levels of myristoylated peptide were required for optimal activity (100 M) (34,35), raising the possibility that the effect was due to some residual activity in the amino terminus of ARF1.…”
Section: Fig 7 Ap-1 and Coatomer Bindingmentioning
confidence: 80%
“…Thus, microinjection of anticoatomer antibodies into cells was found to prevent transport of the VSV-G protein from the endoplasmic reticulum to the Golgi, but not to affect its delivery from the TGN to the cell surface (17). Another study found that a cytosol depleted of coatomer fully supported the formation of secretory vesicles from a TGN-containing membrane preparation of PC12 cells (12). Recently, it was also observed that, after purification, post-Golgi vesicles generated in vitro from MDCK Golgi fractions containing the VSV-G protein contained no detectable levels of the COPI polypeptide ␤COP (18).…”
mentioning
confidence: 86%
“…14), and are primarily concentrated at the entry face of the Golgi apparatus, but are also localized in the TGN (15) and on endosomes (16). However, several reports (12,17,18) have concluded that coatomer coats are not involved in the production of TGN-derived exocytic vesicles. Thus, microinjection of anticoatomer antibodies into cells was found to prevent transport of the VSV-G protein from the endoplasmic reticulum to the Golgi, but not to affect its delivery from the TGN to the cell surface (17).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…ARF1 also localizes to the TGN in plants (Robinson et al, 2011) and has been demonstrated to have the capacity to mediate COPI-independent vesicle formation at the TGN in a cell-free system derived from PC12 cells (pheochromocytoma of the rat adrenal medulla) (Barr and Huttner, 1996). Interestingly, inhibiting BIG1-4 function does not affect COPI localization (Richter et al, 2014).…”
Section: Arf1 Gtpases Mediate Ethylene-regulated Hook Development Andmentioning
confidence: 99%